February 2021 FDA Recall Drug by Jubilant Cadista Pharmaceuticals, Inc.
D-0298-2021 - Labeling

This Class III drug recall was voluntarily initiated by Jubilant Cadista Pharmaceuticals, Inc. on February 19, 2021 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0298-2021

Reason for Recall
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
Initiated
02-19-2021
Reported
03-10-2021
Quantity
635,400 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Jubilant Cadista Pharmaceuticals, Inc.
USA nationwide, including Puerto Rico.
Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

Batch or Lot Expiration Information

Lot# : 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022